Vimarsana
Biggest News Aggregation in the World

Scleroderma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scleroderma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scleroderma Program Today - Breaking & Trending Today

Health notes | News, Sports, Jobs - Tribune Chronicle - Vimarsana News

Health notes | News, Sports, Jobs - Tribune Chronicle

WELLNESS ON WHEELS: Local venues will host the Warren City Health District’s “Wellness on Wheels” Mobile Health Unit. The vehicle has visited each ward in

Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial - Vimarsana News

Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial

In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.

UCLA in the News February 2, 2022 - Vimarsana News

UCLA in the News February 2, 2022

Highlights from the Los Angeles Times, the Washington Post, CNN and others.

Source: ucla.edu
Chemomab Therapeutics Announces Collaboration with Leeds University to Further Elucidate the Role of CCL24 in Vascular Damage Associated with Systemic Sclerosis - Vimarsana News

Chemomab Therapeutics Announces Collaboration with Leeds University to Further Elucidate the Role of CCL24 in Vascular Damage Associated with Systemic Sclerosis

/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) ("Chemomab"), a clinical-stage biotech company focused on the discovery and development of innovative...

New research finds connection: Inflammation, metabolism and scleroderma scarring - Vimarsana News

New research finds connection: Inflammation, metabolism and scleroderma scarring

 E-Mail Scleroderma, a chronic and currently incurable orphan disease where tissue injury causes potentially lethal skin and lung scarring, remains poorly understood. However, the defining characteristic of systemic sclerosis, the most serious form of scleroderma, is irreversible and progressive scarring that affects the skin and internal organs. Published in "We found that scleroderma inflammation dramatically increases CD38, an enzyme that normally breaks down a metabolic nutrient, NAD+. When NAD+ levels decrease, tissue injury becomes chronic and progresses to scar formation rather than...